Oncology-Cancer Drugs Market Expected to reach $274.40 Billion by 2030 | By Allied Market Research

The global oncology drugs market size was valued at $135,494.17 million in 2020, and is projected to reach $274,400.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.

14 Reasons You Can Blame the Recession on Oncology/cancer Drugs Market

Furthermore, the global oncology/cancer drugs market growth is propelled by surge in geriatric population, increase in collaboration between pharmaceutical companies for development of novel cancer drugs, and rise in awareness associated with early detection of cancer among populace.

Oncology-Cancer Drugs Market | Industry, Revenue & Trends Analysis From 2021 To 2030

The global oncology drugs market size was valued at $135,494.17 million in 2020, and is projected to reach $274,400.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.

In the Crowded Oncology/Cancer Drugs Market, There’s Room for Revenue Growth

Increase in incidence of cancer, rise in the global geriatric population, and surge in government expenditure on healthcare have boosted the global oncology/cancer drugs market. However, adverse effect associated with use of cancer drugs hinders the market growth. On the contrary, rise in number of pipeline drugs and high growth potential in untapped emerging economies …